Embecta Corp. (EMBC)
NASDAQ: EMBC · Real-Time Price · USD
9.07
-0.37 (-3.92%)
At close: Mar 6, 2026, 4:00 PM EST
9.10
+0.03 (0.33%)
After-hours: Mar 6, 2026, 7:48 PM EST
Embecta Market Cap
Embecta has a market cap or net worth of $537.12 million as of March 6, 2026. Its market cap has decreased by -35.88% in one year.
Market Cap
537.12M
Enterprise Value
1.75B
1-Year Change
-35.88%
Ranking
Category
Stock Price
$9.07
Market Cap Chart
Since March 22, 2022, Embecta's market cap has decreased from $2.68B to $537.12M, a decrease of -79.93%. That is a compound annual growth rate of -33.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 537.12M | -23.64% |
| Dec 31, 2025 | 703.44M | -41.40% |
| Dec 31, 2024 | 1.20B | 10.14% |
| Dec 29, 2023 | 1.09B | -24.67% |
| Dec 30, 2022 | 1.45B | -45.94% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AtriCure | 1.51B |
| Kestra Medical Technologies | 1.38B |
| Pulse Biosciences | 1.26B |
| Azenta | 1.14B |
| BioLife Solutions | 971.80M |
| Anbio Biotechnology | 956.83M |
| STAAR Surgical Company | 919.45M |
| Anteris Technologies Global | 597.64M |